Both Low Blood Glucose and Insufficient Treatment Confer Risk of Neurodevelopmental Impairment in Congenital Hyperinsulinism: A Multinational Cohort Study

Autor: Inna Shcherderkina, Karen Filipsen, Klaus Brusgaard, Lars Kjærsgaard Hansen, Annett Helleskov, Maria Melikyan, Charlotte Dahl Christiansen, Evgenia Globa, Anna-Maria Larsen, Henrik Thybo Christesen, Fani Poertner

Publikováno v: Frontiers in Endocrinology, Vol 8 (2017)
Rasmussen, A H, Melikyan, M, Globa, E, Shcherderkina, I, Poertner, F, Larsen, A-M, Filipsen, K, Brusgaard, K, Dahl Christiansen, C, Hansen, L K & Christesen, H B T 2017, ' Both Low Blood Glucose and Insufficient Treatment Confer Risk of Neurodevelopmental Impairment in Congenital Hyperinsulinism : A Multinational Cohort Study ', Frontiers in Endocrinology, vol. 8, no. JUL, 156 . https://doi.org/10.3389/fendo.2017.00156
Frontiers in Endocrinology

BACKGROUND/AIMS: Congenital hyperinsulinism (CHI) is a heterogeneous disease most frequently caused by KATP-channel (ABCC8 and KCNJ11) mutations, with neonatal or later onset, variable severity, and with focal or diffuse pancreatic involvement as the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::910b1f7d4675d7be74b04b0321f1667a